Literature DB >> 28265802

Translation and Adaptation of the Genetic Counselling Outcome Scale (GCOS-24) for Use in Denmark.

Birgitte Rode Diness1,2, Gritt Overbeck3, Tina Duelund Hjortshøj4, Trine Bjørg Hammer4, Susanne Timshel4, Else Sørensen4, Marion McAllister5.   

Abstract

Outcome measurement in clinical genetics is challenging. Robust outcome measures are needed to provide evidence to support service development within genetic counseling. The Genetic Counselling Outcome Scale (GCOS-24), a Patient Reported Outcome Measure (PROM), was developed in English and validated with clinical genetics patients in the British NHS. This study reports the translation and adaptation of the GCOS-24 for use in Denmark. GCOS-24 was translated and back translated, supervised by an expert committee. Feedback on the first version was collected from genetic counseling patients in qualitative interviews focusing on instructions for use, response options and specific items considered semantically difficult. After further adjustment the adapted and translated version was administered to a second sample of patients, with responses analyzed using descriptive statistics. Eighteen interviews were conducted, and led to adjustment of item wording. Sixty-one patients completed the final version GCOS-24dk. Internal consistency is good (Cronbach's α =0.79), with an acceptable number of missing responses and no floor or ceiling effect observed. GCOS-24 has been successfully translated and adapted for use in a Danish setting. The study confirms the feasibility of local adaptation of patient reported outcome measures and stresses the importance of adaptation, even across quite similar populations and health care systems.

Entities:  

Keywords:  Empowerment; Genetic counseling; PROM; Translation and cultural adaptation

Mesh:

Year:  2017        PMID: 28265802     DOI: 10.1007/s10897-017-0086-7

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  35 in total

Review 1.  Re-conceptualizing risk in genetic counseling: implications for clinical practice.

Authors:  Jehannine C Austin
Journal:  J Genet Couns       Date:  2010-01-30       Impact factor: 2.537

Review 2.  Understanding the minimum clinically important difference: a review of concepts and methods.

Authors:  Anne G Copay; Brian R Subach; Steven D Glassman; David W Polly; Thomas C Schuler
Journal:  Spine J       Date:  2007-04-02       Impact factor: 4.166

3.  Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part 1.

Authors:  P W Stratford; J M Binkley; D L Riddle; G H Guyatt
Journal:  Phys Ther       Date:  1998-11

Review 4.  A point of minimal important difference (MID): a critique of terminology and methods.

Authors:  Madeleine T King
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-04       Impact factor: 2.217

5.  Commentary: the patient-reported outcome measurement information system (PROMIS®) for children and youth: application to pediatric psychology.

Authors:  Christopher B Forrest; Katherine B Bevans; Carole Tucker; Anne W Riley; Ulrike Ravens-Sieberer; William Gardner; Kathleen Pajer
Journal:  J Pediatr Psychol       Date:  2012-02-23

6.  A scaled version of the General Health Questionnaire.

Authors:  D P Goldberg; V F Hillier
Journal:  Psychol Med       Date:  1979-02       Impact factor: 7.723

7.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

Authors:  M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

8.  The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services.

Authors:  M McAllister; A M Wood; G Dunn; S Shiloh; C Todd
Journal:  Clin Genet       Date:  2011-02-14       Impact factor: 4.438

9.  Using patient-reported outcomes (PROs) to compare the providers of surgery: does the choice of measure matter?

Authors:  Jenny Neuburger; Andrew Hutchings; Jan van der Meulen; Nick Black
Journal:  Med Care       Date:  2013-06       Impact factor: 2.983

10.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

View more
  4 in total

1.  Translation and Cross-Cultural Adaptation with Preliminary Validation of GCOS-24 for Use in Spain.

Authors:  Patricia Muñoz-Cabello; Sixto García-Miñaúr; Manuel Eliecer Espinel-Vallejo; Lorenzo Fernández-Franco; Alexandra Stephens; Fernando Santos-Simarro; Pablo Lapunzina-Badía; Marion McAllister
Journal:  J Genet Couns       Date:  2017-09-25       Impact factor: 2.537

Review 2.  Incorporating patient perspectives in the development of a core outcome set for reproductive genetic carrier screening: a sequential systematic review.

Authors:  Ebony Richardson; Alison McEwen; Toby Newton-John; Ashley Crook; Chris Jacobs
Journal:  Eur J Hum Genet       Date:  2022-03-28       Impact factor: 5.351

3.  Understanding Adult Participant and Parent Empowerment Prior to Evaluation in the Undiagnosed Diseases Network.

Authors:  Christina G S Palmer; Allyn McConkie-Rosell; Ingrid A Holm; Kimberly LeBlanc; Janet S Sinsheimer; Lauren C Briere; Naghmeh Dorrani; Matthew R Herzog; Sharyn Lincoln; Kelly Schoch; Rebecca C Spillmann; Elly Brokamp
Journal:  J Genet Couns       Date:  2018-03-01       Impact factor: 2.537

4.  Adaptation and validation of the Genetic Counseling Outcome Scale for autism spectrum disorders and related conditions.

Authors:  Afiqah Yusuf; Iskra Peltekova; Tal Savion-Lemieux; Jennifer Frei; Ridha Joober; Jennifer Howe; Stephen W Scherer; Mayada Elsabbagh
Journal:  J Genet Couns       Date:  2020-09-06       Impact factor: 2.537

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.